These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3727508)

  • 1. [Use of a radioimmunologic analysis method in oncologic examinations of high-risk groups].
    Chebotareva ED; Skliar SIu
    Vrach Delo; 1986 May; (5):5-8. PubMed ID: 3727508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of 4 tumor-associated antigens in the evaluation of the spread of breast carcinoma].
    Stefanović L; Kamenjicki E; Selir Z; Miljković L; Sterio B; Semnic R; Sljapić N
    Med Pregl; 1984; 37(3-4):107-12. PubMed ID: 6208469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of cancer-controlling examinations].
    Boyes DA; Knowélden J; Phillips AJ
    Dtsch Med Wochenschr; 1974 Jan; 99(3):102-4. PubMed ID: 4812776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers in breast cancer].
    Polevaia EB; Tkacheva GA; Letiagin VP; Ivanov VM; Koposova TL
    Sov Med; 1985; (3):25-9. PubMed ID: 4023831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of calcitonin, prolactin and carcino-embryonic antigen during the treatment of breast cancer in menopausal patients].
    Tkacheva GA; Moroz LV; Polevaia EB
    Vestn Akad Med Nauk SSSR; 1984; (10):88-94. PubMed ID: 6506860
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen in breast nipple aspirate fluid.
    Foretova L; Garber JE; Sadowsky NL; Verselis SJ; Joseph DM; Andrade AF; Gudrais PG; Fairclough D; Li FP
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):195-8. PubMed ID: 9521431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunochemical analysis in the evaluation of the effectiveness of drug therapy of breast cancer in women of reproductive age].
    Tkacheva GA; Moroz LV; Ivanov VM
    Vestn Akad Med Nauk SSSR; 1984; (5):54-60. PubMed ID: 6741250
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammography and clinical breast examinations among women aged 50 years and older--Behavioral Risk Factor Surveillance System, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(38):737-41. PubMed ID: 8371707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk groups and screening for cancer.
    Jensen OM
    Cancer Detect Prev; 1982; 5(3):343-8. PubMed ID: 7151068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of breast cancer: results of a screening programme.
    Beahrs OH
    Ann R Coll Surg Engl; 1980 Jan; 62(1):38-40. PubMed ID: 7362187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mammography screening for breast cancer].
    Drozdz W; Strzałka M
    Przegl Lek; 1998; 55(12):663-8. PubMed ID: 10354718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early diagnosis of breast tumours.
    Ghys R
    J Nucl Med Allied Sci; 1983; 27(4):317-25. PubMed ID: 6674431
    [No Abstract]   [Full Text] [Related]  

  • 16. [A suggestion for screening examinations for breast cancer].
    Głuszek S
    Wiad Lek; 1982 Aug; 35(11-12):751-5. PubMed ID: 7135977
    [No Abstract]   [Full Text] [Related]  

  • 17. The National Study of Breast Cancer Screening Protocol for a Canadian Randomized Controlled trial of screening for breast cancer in women.
    Miller AB; Howe GR; Wall C
    Clin Invest Med; 1981; 4(3-4):227-58. PubMed ID: 6802546
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening and risk group concepts in oncology (author's transl)].
    Berndt H
    Arch Geschwulstforsch; 1981; 51(8):655-61. PubMed ID: 7340711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers as prognostic and clinical evaluation tools.
    Tormey DC; Waalkes TP
    Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carcino-embryonic antigen and ferritin during the treatment of patients with primary and metastatic cancer of the liver].
    Roshchin EM; Ostrovtsev IV; Komov DV
    Vestn Akad Med Nauk SSSR; 1984; (10):78-81. PubMed ID: 6506858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.